The AMNOG-Monitor now has a fresh look. After rebuilding the platform from the ground up last year to handle additional data sources such as EU-HTA and arbitration rulings, we've also given it a more modern and user-friendly design. All existing features remain in place. The biggest update is to the smart search, which now also covers Module 4, ongoing clinical trials, and product information (Fachinformationen). Another addition is the quantification of patient-relevant endpoints with effect measures such as HR, 95% confidence intervals, and p-values. The first JCA and EU dossiers will be available in the AMNOG-Monitor as soon as they are published.